Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Clasificación en acciones #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Precio por acción
$50.95
Capitalización bursátil
$226.41B
Cambio (1 día)
2.58%
Cambio (1 año)
-26.16%
País
DK
Comercio Novo Nordisk A/S (NVO)

Categoría

Historial de desdoblamientos de acciones de Novo Nordisk A/S (NVO)
La acción Novo Nordisk A/S (símbolo: NVO) tuvo un total de 5 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 20, 2023.
Una acción NVO comprada antes de Apr 18, 1994 equivaldría hoy a 200 acciones NVO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2023-09-20 2:1 x2 x200
2014-01-09 5:1 x5 x100
2007-12-17 2:1 x2 x20
2001-04-11 5:2 x2.5 x10
1994-04-18 4:1 x4 x4
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
0 -
BE
0 -
NL
0 -
US